Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | GAA | P10253 | 4/20 | 1.00 |
| ▸ | GLA | P06280 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KDM6B | O15054 | 1/20 | 0.61 |
| ▸ | KDM4A | O75164 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.56 |
| ▸ | CFTR | P13569 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | CASP1 | P29466 | 2/20 | 0.51 |
| ▸ | CASP7 | P55210 | 2/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29464551 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EGAAGLAMAPT | |
| SCHEMBL30419031 | 0.85 | ALDH1A1 (0.74) | ALDH1A1KDM4EGAAGLAMAPT | |
| SCHEMBL1062129 | 0.85 | ALDH1A1 (0.74) | ALDH1A1KDM4EGAAGLAMAPT | |
| SCHEMBL68952 | 0.82 | KDM4E (0.70) | ALDH1A1KDM4EGAAGLAL3MBTL1 | |
| SCHEMBL29416299 | 0.82 | KDM4E (0.70) | ALDH1A1KDM4EGAAGLAL3MBTL1 | |
| SCHEMBL5768957 | 0.81 | ALDH1A1 (0.69) | ALDH1A1KDM4EGAAGLAMAPT | |
| SCHEMBL29790003 | 0.81 | ALDH1A1 (0.68) | ALDH1A1KDM4EGAAGLAMAPT | |
| SCHEMBL1841640 | 0.81 | ALDH1A1 (0.68) | ALDH1A1KDM4EGAAGLAMAPT | |
| SCHEMBL31487718 | 0.81 | ALDH1A1 (0.68) | ALDH1A1KDM4EGAAGLAMAPT | |
| SCHEMBL3890104 | 0.80 | ALDH1A1 (0.67) | ALDH1A1KDM4EGAAGLAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113387881-B | Synthesis method of 3-aminoisonicotinic acid methyl ester | 安徽大学 | 2024-05-14 | — | — | CN | claimed |
| CN-114907318-B | Isonicotinic acid-pyrazole derivative and preparation method and application thereof | 郑州大学 | 2023-08-11 | — | — | CN | claimed |
| CN-116426219-A | Chemical mechanical polishing solution and application thereof | 安集微电子科技(上海)股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-116023430-A | 2- (2- (2-benzoylamino) acetamide) benzoic acid derivative and preparation method and application thereof | 中国药科大学 | 2023-04-28 | — | — | CN | claimed |
| CN-114686112-A | Chemical mechanical polishing solution and use method thereof | 安集微电子科技(上海)股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-113387881-A | Synthetic method of 3-amino methyl isonicotinate | 安徽大学 | 2021-09-14 | — | — | CN | claimed |
| CN-111100068-A | Method for quickly and efficiently synthesizing 3-amino methyl isonicotinate | 苏州诚和医药化学有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-111018775-A | High-yield synthesis method of 3-amino methyl isonicotinate | 苏州诚和医药化学有限公司 | 2020-04-17 | — | — | CN | claimed |
| US-12637428-B2 | Isoquinoline derivatives as SIK2 inhibitors | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2026-05-26 | — | — | US | disclosed |
| US-20260125346-A1 | Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of Disease | BEONE MEDICINES I GMBH (CH) | 2026-05-07 | — | — | US | disclosed |
| EP-4709711-A1 | ISOQUINOLINONE DERIVATIVES AND 4H-QUINOLIZINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASE | Beone Medicines I GmbH (CH) | 2026-03-18 | — | — | EP | disclosed |
| US-20250320204-A1 | 7-AZA BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS | RIBOSCIENCE LLC (US) | 2025-10-16 | — | — | US | disclosed |
| EP-4615454-A1 | SOS1 INHIBITORS | Acerand Therapeutics (Hong Kong) Limited (HK) | 2025-09-17 | — | — | EP | disclosed |
| US-20250163043-A1 | CDK9 INHIBITOR AND USE THEREOF | TRANSTHERA SCIENCES (NANJING), INC. (CN) | 2025-05-22 | — | — | US | disclosed |
| US-5700940-A | FOR PRE- OR POSTEMERGENCE SPRAYING OF PLANTS OR SOILS | DOWELANCO (US) | 1997-12-23 | — | — | US | disclosed |
| US-5614469-A | N-pyridinyl[1,2,4]triazolo[1,5-c]pyrimidine-2-sulfonamide herbicides | DOWELANCO (US) | 1997-03-25 | — | — | US | disclosed |
| US-5571775-A | EFFECTIVE ON A BROAD SPECTRUM OF VEGETATION AT LOW APPLICATION RATES | DOWELANCO (US) | 1996-11-05 | — | — | US | disclosed |
| EP-0717745-A1 | N-PYRIDINYL 1,2,4]TRIAZOLO 1,5-C]PYRIMIDINE-2-SULFONAMIDE HERBICIDES | DOWELANCO (US) | 1996-06-26 | — | — | EP | disclosed |
| WO-1996001828-A1 | N-PYRIDINYL[1,2,4]TRIAZOLO[1,5-C]PYRIMIDINE-2-SULFONAMIDE HERBICIDES | DOWELANCO (US) | 1996-01-25 | — | — | WO | disclosed |
| US-5461161-A | Chemical intermediate is 3-amino-2-hal pyridine | DOWELANCO (US) | 1995-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637428-B2 | Isoquinoline derivatives as SIK2 inhibitors | SIK2, SIK1, SIK3 | ALDH1A1 4757/4885KDM4E 1688/4885GAA 3848/4885 |
| US-20250320204-A1 | 7-AZA BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS | ENPP1, ENPP3, PDE7A | ALDH1A1 745/4885KDM4E 1820/4885GAA 188/4885 |
| US-20260125346-A1 | Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of Disease | NR3C1, NR3C2, PIK3R4 | ALDH1A1 1598/4885KDM4E 3237/4885GAA 1003/4885 |
| US-20250163043-A1 | CDK9 INHIBITOR AND USE THEREOF | CDK9, CDK19, CDKL1 | ALDH1A1 2791/4885KDM4E 510/4885GAA 1906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.